Market cap
$3.8b
End-of-day close multiplied by current shares on issue.
FBU · NZX
Fletcher Building is an NZX-listed construction & materials / building products and construction company. Its latest covered result is FY26, with FY21 - FY26 of source-backed result history on Annolyse.
Latest result
FY26, released 19 August 2026
| Metric | Value | Change |
|---|---|---|
| Revenue | $7b | ↑ +0.7% |
| EBITDA | $731m | ↑ +381.2% |
| NPAT | $228m | ↑ +154.4% |
| Operating cash flow | $715m | ↑ +42.7% |
| OCF / EBITDA % | 97.8% | ↑ +290.5pp |
| ROE % | 5.8% | ↑ +17.4pp |
| FCF pre-lease | $427m | ↑ +127.1% |
| Total assets | $7.5b | ↓ -5.3% |
Source: latest published briefing (FY26, released 19 August 2026). Change compares against the prior equivalent period: FY25, released 20 August 2025.
Valuation
Trailing P/E, EV/EBITDA, price-to-book and price-to-free-cash-flow ratios combine the latest available close with filing data. They are comparative measures, not forecasts or recommendations.
The latest close and share count context for the market price.
Market cap
$3.8b
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
16.75x
Recent market cap compared with trailing earnings.
EPS
0.21
Recent filing-derived earnings per share.
PEG
Not available
Not available for this company right now.
EV/EBITDA
Not available
Not available for this company right now.
P/FCF
8.94x
Market cap compared with recent free cash flow.
P/B
0.96x
Market value compared with latest reported equity.
Yield and investment-company valuation where supported.
Dividend yield
0.0%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Daily closes use the full available width, with hover and touch values for each observation. Expand the chart to see more detail.
Five years of daily closes, as at close, 5 June 2026. Weekends, suspensions, and listing gaps stay as natural gaps in the time scale.
Filing-period markers only: EOD close on or before each release date divided by filing-derived trailing NPAT where both inputs verify. Periods with P/E at or above 100x are shown as gaps because earnings yield below 1% makes the multiple denominator-driven, not meaningful. Suppressed periods: HY24.
Chat
Ask follow-up questions about Fletcher Building's latest result and company history.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Financial history
The latest period is shown first.
| Metric | FY2612 MONTHS19 August 2026 | HY266 MONTHS18 February 2026 | FY2512 MONTHS20 August 2025 | HY256 MONTHS19 February 2025 | FY2412 MONTHS21 August 2024 | HY246 MONTHS14 February 2024 | FY2312 MONTHS16 August 2023 | HY236 MONTHS15 February 2023 | FY2212 MONTHS17 August 2022 | HY226 MONTHS16 February 2022 | FY2112 MONTHS18 August 2021 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7b | $2.9b | $7b | $3.6b | $7.7b | $4.2b | $8.5b | $4.3b | $8.5b | $4.1b | $8.1b | Chart |
| Revenue growth % | -2.4% | -20.0%Unprecedented low revenue growth. -20%; 4-period range -15.7% to 5.4%. Revenue growth: -20.0%, unprecedented low; 4-period mean -2.3%, range -15.7%-5.4%. | -9.0% | -15.7%Outside range low revenue growth. -15.7%; 3-period range -0.8% to 5.4%. Revenue growth: -15.7%, below normal range; 3-period mean 2.2%, range -0.8%-5.4%. | -9.3%Outside range low revenue growth. -9.3%; 3-period range -0.3% to 11.1%. Revenue growth: -9.3%, below normal range; 3-period mean 5.2%, range -0.3%-11.1%. | -0.8% | -0.3% | 5.4% | 4.7% | 1.9% | 11.1% | Chart
|
| EBITDA | $731m | $331m | -$260m | $346m | $846m | $455m | $497m | $540m | $1.1b | $504m | $1b | Chart |
| EBITDA margin % | 10.4% | 11.5% | -3.7% | 9.7%Outside range low ebitda margin. 10%; 3-period range 10.7% to 12.6%. EBITDA margin: 10.0%, below normal range; 3-period mean 11.9%, range 10.7%-12.6%. | 11.0% | 10.7% | 5.9% | 12.6% | 13.0% | 12.4% | 12.7% | Chart
|
| PBT | — | $65m | -$432m | -$123m | -$24m | -$138m | $343m | $137m | $598m | $237m | $433m | Chart |
| PBT growth % | — | — | — | — | — | — | -42.6% | -42.2% | 38.1% | 30.9% | — | Chart |
| NPAT | $228m | -$11m | -$419m | -$134m | -$227m | -$120m | $235m | $92m | $432m | $171m | $305m | Chart |
| NPAT growth % | — | — | — | — | — | — | -45.6% | -46.2% | 41.6% | 41.3% | — | Chart |
| Operating cash flow | $715m | $156m | $501m | -$5m | $398m | -$126m | $388m | -$203m | $592m | $157m | $889m | Chart |
| OCF / EBITDA % | 97.8% | 47.1%Unprecedented high ocf / ebitda cash conversion. 47.1%; 4-period range -37.6% to 31.2%. OCF / EBITDA cash conversion: 47.1%, unprecedented high; 4-period mean -8.9%, range -37.6%-31.2%. | -192.7% | -1.4% | 47.0% | -27.7% | 78.1% | -37.6% | 53.5% | 31.2% | 86.1% | Chart
|
| FCF pre-lease | $427m | $6m | $188m | -$166m | -$31m | -$314m | -$57m | -$443m | $193m | $17m | $658m | Chart |
| DPS | — | — | — | 0.0c | — | — | 16.0c | 18.0c | 22.0c | 18.0c | 18.0c | Chart |
| Payout ratio vs NPAT % | — | — | — | — | — | — | 113.3% | 153.8% | 74.8% | 85.7% | 81.1% | Chart |
| Annual payout ratio vs EPS % | — | — | — | — | — | — | 113.3% | — | 74.8% | — | 81.1% | Chart |
| ROE % | 5.8% | -0.3% | -11.6%Unprecedented low roe. -11.6%; 4-period range -6.5% to 11.5%. ROE: -11.6%, unprecedented low; 4-period mean 4.9%, range -6.5%-11.5%. | -3.4%Outside range low roe. -7.3%; 3-period range -3.5% to 4.6%. ROE: -7.3%, below normal range; 3-period mean 1.2%, range -3.5%-4.6%. | -6.8%Outside range low roe. -6.5%; 3-period range 6.4% to 11.5%. ROE: -6.5%, below normal range; 3-period mean 8.7%, range 6.4%-11.5%. | -3.5% | 6.4% | 2.5% | 11.5% | 4.6% | 8.1% | Chart
|
| Net debt | — | — | — | $1.2b | $1.8b | — | $1.4b | $1.4b | — | $457m | — | Chart |
| Net debt / EBITDA | — | — | — | 3.38x | 2.12x | — | 2.89x | 2.66x | — | 0.91x | 0.17x | Chart |
| Debtor days | — | 45 | 32 | 39 | 30Outside range low debtor days. 30d; 3-period range 36d to 51d. Debtor days: 30.2 days, below normal range; 3-period mean 41.4 days, range 36.3 days-50.7 days. | 42 | 51 | — | 36 | 49 | 37 | Chart
|
| Inventory days | — | 122Outside range high inventory days. 123d; 3-period range 69d to 96d. Inventory days: 122.5 days, above normal range; 3-period mean 79.0 days, range 68.7 days-96.0 days. | 99Outside range high inventory days. 100d; 4-period range 65d to 90d. Inventory days: 99.5 days, above normal range; 4-period mean 77.2 days, range 64.7 days-89.7 days. | 69 | 89 | 96 | 90 | 72 | 65 | 72 | 66 | Chart
|
| Total assets | $7.5b | $7.7b | $7.9b | $8.4b | $8.9b | $8.9b | $9.1b | $8.8b | $8.4b | $7.9b | $8b | Chart |
Reference: annolyse.ai/companies/fbu
Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.
These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.
Reported revenue across covered periods.
Like-period revenue growth where comparable.
Company-specific earnings measure where disclosed.
EBITDA-equivalent margin where revenue and earnings are source-backed.
Statutory profit after tax.
Cash generated from operations.
Additional filing-backed metrics for this company. Each point links to the relevant published briefing.
Cash conversion against earnings.
Operating cash flow less capex before leases.
Return on equity.
Borrowings less cash; negative values indicate net cash.
Leverage ratio, suppressed where earnings are not meaningful.
Dividend per share declared for the period.
Dividend payout against statutory NPAT.
Receivables days where the working-capital inputs are source-backed.
Inventory days where the working-capital inputs are source-backed.
Per-period working-capital absorption or release, from the same published history. Positive values are working-capital build; negative values are release.
The setup & the reality
The latest result is checked against what the prior briefing said to watch.
Historical setup
Previous analysisHY26Result releasedAnnolyse analysis published
From PBT swung to $65m profit but inventory days reached 122.5
No FY26 target was supplied. Shape context shows HY25 carried 51.2% of FY25 revenue but only 32% of the -$419m FY25 NPAT, indicating second-half-weighted losses in the prior year. HY26 OCF of $156m compares with FY25's full-year $501m (implied 2H25 of $506m), so the year-on-year improvement is genuine but not yet at the run-rate needed to close the gap to dividend resumption.
Net debt of $1.2b sits materially above the upper bound of the $400m-$900m policy range that gates dividends. The release does not state a timeline for reaching that band, which means dividend re-rating remains a function of further asset sales and working-capital release rather than a disclosed plan.
Open questions
This briefing cannot assess the durability of operating improvement without segment-level prior-period comparatives or a stated FY26 EBITDA bridge.
Primary issuer documents used for the FY26 briefing. Document labels are preserved from the publication record; Annolyse does not relabel every financial report as an annual report.
2026 Annual Report
FY26 / financial report2026 Annual Report
FY25 / financial reportPeer context
These companies share a broad sector but may not be direct peers. Compare them only where the underlying measures are genuinely comparable.
Archive
The full chronological archive contains every published result briefing.
FY26 · Released 19 August 2026
Current-filed Group rows correct the truncated revenue extraction and keep adjusted EBITDA, continuing earnings and cash scopes explicit.
HY26 · Released 18 February 2026
A 152.8% PBT recovery and positive pre-lease FCF coexist with inventory days 40 above the historical mean of 82.5.
FY25 · Released 20 August 2025
$644m of continuing-operation significant items drove PBT margin to an unprecedented -6.2%, while a balance-sheet recapitalisation cut net debt
HY25 · Released 19 February 2025
PBT loss narrowed 10.9% to NZ$123.0m yet NPAT loss widened 11.7% to NZ$134.0m as discontinued Tradelink absorbed NZ$52.0m.
FY24 · Released 21 August 2024
Operating cash flow held up only because working capital released $473m, masking weaker underlying earnings as the dividend was suspended.
HY24 · Released 14 February 2024
Significant items including a NZ$122m Tradelink write-down masked NZ$455m of underlying EBITDA, but leverage rose to 4.3x and the interim dividend
Get the next Fletcher Building result briefing and five-year history updates by email.